Keyphrases
Treatment Options
100%
Capecitabine
100%
Locally Advanced
100%
Anal Carcinoma
100%
Chemoradiotherapy
100%
5-fluorouracil (5-FU)
87%
Radiotherapy
37%
Mitomycin C
37%
Log-rank Test
37%
Overall Survival
25%
As(V)
25%
Colostomy-free Survival
25%
Clinical Complete Response
25%
GSTT1
25%
Locoregional Control
25%
Genotype
12%
Genetic Polymorphism
12%
GSTP1
12%
Complete Response Rate
12%
Colorectal Cancer
12%
Treatment Alternatives
12%
Anal Canal Carcinoma
12%
GSTM1
12%
Acceptable Alternatives
12%
Free Association
12%
Medicine and Dentistry
Capecitabine
100%
Chemoradiotherapy
100%
Anus Carcinoma
100%
Fluorouracil
87%
Log Rank Test
37%
Mitomycin
37%
Radiation Therapy
37%
Overall Survival
25%
Colostomy
25%
Squamous Cell
12%
Rectum Cancer
12%
Retrospective Study
12%
Genetic Polymorphism
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Anus Carcinoma
100%
Capecitabine
100%
Fluorouracil
87%
Mitomycin
37%
Overall Survival
25%
Retrospective Study
12%
Rectum Cancer
12%
Biochemistry, Genetics and Molecular Biology
Capecitabine
100%
Fluorouracil
87%
GSTT1
25%
Overall Survival
25%
Genetic Polymorphism
12%
GSTP1
12%
Retrospective Study
12%